History

History

Horizon Robotics is a short public-company story — listed October 24, 2024 — but a long private-company arc dating to a July 2015 spin-out from Baidu's Institute of Deep Learning. The story has changed twice: from "energy-efficient AI chips for many devices" (2015–2019) to "automotive-grade smart-driving silicon for the Chinese OEM" (2020–2023) to today's "full-stack ADAS+AD platform with global tier-one partnerships and a robotics adjacency" (2024 onward). Founder-CEO Dr. Yu Kai has held the seat the entire ten years; every promise the company has made as a listed entity — 10 million cumulative Journey shipments, HSD mass production by Q3 2025, 50% multi-year revenue growth — has been met or beaten. Credibility is high but the public track record is short, and the share price has drifted from a January 2025 peak near HK$11 to roughly HK$6.26 today as the market discounts the gap between operating losses and the 2027 profitability promise.

1. The Narrative Arc

For four years (FY2021–FY2024) operating losses sat in a striking ¥2.0–2.2B band while revenue compounded above 50% annually — heavy R&D ahead of the silicon-volume curve. FY2025 broke that band: H1 2025 alone produced an operating loss of ¥1,592M (versus ¥1,105M in H1 2024, +44%), so the full-year operating loss is likely closer to ¥3.0B as R&D scaled faster than revenue and gross-margin mix shifted toward lower-margin product solutions. Management did not flag the wider loss in the H2 2025 results — they instead raised the multi-year revenue growth guide from 50% to 60%, which is the one place to watch for tonal divergence between top-line confidence and bottom-line drift.

Three real inflection points anchor the arc:

1. 2020–2021 — Becoming an automotive company. The 2017 Journey 1 launch was for "intelligent devices broadly." By 2020, with Journey 2 in mass production and Li Auto, BYD and SAIC engaged, the consumer-IoT ambition was quietly replaced by an automotive-only identity. The Sunrise (surveillance/IoT) chip line still exists but vanished from the equity story.

2. October 2022 — The Volkswagen anchor. VW Group's $2.3B commitment to the CARIZON joint venture transformed Horizon from "credible Chinese supplier" to "the only non-Western auto-AI platform a global OEM trusted with software ownership." Without this, the IPO narrative would have been domestic-only.

3. April 2024 — Journey 6 + HSD reveal. The first time Horizon positioned itself not as a chip vendor but as a full-stack autonomy provider competing with Nvidia Drive Thor on system performance. Six months later, the IPO priced at the top of range.

2. What Management Emphasized — and Then Stopped Emphasizing

The pivots that show up: "Energy efficiency" was the lead phrase on every press release through 2023 — the descriptor in a typical headline read "energy-efficient computing solutions for ADAS." By the FY2024 annual report it is gone, replaced by "leading provider of ADAS and autonomous driving solutions." The 2015-era IoT/Sunrise chip pitch is essentially extinct in investor communications. In the other direction, "global tier-one partnerships" (Aptiv, ZF, Bosch, DENSO) and "robotics / embodied AI" (Riemann BPU, HoloMotion/HoloBrain models) have grown from absent to prominent in the 2024–2025 window — the platform-and-ecosystem story is becoming the equity story.

The "license and services" revenue line jumped from auxiliary mention to centerpiece in FY2024 (70.9% growth, 92% gross margin) because it is the proof point that the business model has operating leverage. It dipped back in 2025 prominence as management re-anchored on physical SoC volumes (4M+ units) and HSD activations.

3. Risk Evolution

The disclosure-level changes between the October 2024 IPO prospectus and the April 2025 annual report tell a recognizable story for any post-IPO Chinese tech company:

• De-emphasized: capital adequacy concerns (the IPO raised HK$5.4B; cash on balance sheet went from ¥11.4B to ¥15.4B; gearing collapsed from 255.4% to 41.5% as preferred shares converted), foreign IPO/regulatory listing risk (it happened, no SEC clawback), governance concerns around weighted voting rights (now disclosed but no longer described as "execution-stage uncertainty").

• Newly emphasized: "We face risks related to heightened regulatory and public scrutiny on our third-party service providers." This wording, prominent in the 2024 annual report's principal risks summary, is not a generic boilerplate addition — it specifically protects against contagion from supplier or partner controversies (e.g., a CARIZON sub-supplier sanction, an OEM customer's recall). Its addition without a stated trigger is a quiet warning that management thinks the surface area for headline risk just increased.

• Escalated: "OEM and tier-one self-development" — Tesla, Xpeng, NIO, Li Auto and BYD all run internal silicon programs, and management explicitly named this as a principal risk in the 2024 directors' report. CARIZON execution risk also moved up: equity-method losses widened from ¥112M (FY2023) to ¥557M (FY2024) to roughly ¥800M annualized in H1 2025.

4. How They Handled Bad News

There is no full-fat earnings miss yet — the company has only reported one full year and one interim as a public entity. But there are three legitimate disappointments to read management's tone against:

The CARIZON drag. When the JV launched in late 2023 management framed it as "in ramp-up stage" and signposted larger near-term losses. They have not walked that back, but the magnitude has been larger than press coverage suggested at the time of the deal. The FY2024 MD&A: "This increase in loss was primarily attributable to our increased shared loss of CARIZON, which was established in November 2023 and is still in its ramping up stage with increased R&D expenses in 2024." No apology, no reframing — but also no fresh quantification of when the JV turns. Honest if minimal.

The IPO discount. Horizon priced its Hong Kong IPO at HK$3.99 in October 2024, the top of the range, and finance press celebrated it as the largest Hong Kong IPO of 2024. By December 2025, the stock had fallen back below the IPO price for stretches; by May 2026, it sits around HK$6.26 — well off the January 2025 peak (~HK$11) but still ~57% above issue. Management has never publicly addressed the share-price drift in any earnings communication recovered for this period. That is an HKEX-norm stance, but it is also an absence.

The "negative profitability" headline cycle. Multiple sell-side and AI-summary outlets (Meyka, Moomoo, Smartkarma) have run headlines through April–May 2026 framing Horizon as a "concern" stock with negative EPS and a 27x P/S. Management's response has been to not respond — instead reinforcing the operating-cadence narrative with the December 2025 ecosystem conference, the J7 chip leak in March 2026, and the H2 2025 results that raised the multi-year revenue growth guide from 50% to 60%. This is "show, don't tell" — appropriate for a growth-stage company but creates a vacuum that the headline-driven retail flow fills with negativity.

5. Guidance Track Record

Credibility score: 8 / 10.

Five of six concrete public promises have landed cleanly — including the headline 10M-unit shipment milestone, the HSD mass-production date, the H1 2025 SoC volume guide, the ASP expansion thesis, and the related-party transaction cap, which came in at the cap to the dollar. The CARIZON drag is the one item that has gone the wrong way against early IPO framing, and it is a real one — equity-method losses are now a ~¥1B annualized headwind. But it has been disclosed flatly, not minimized.

The score is held below 9 by two things: (a) the public track record is only 1.5 years long, and one good period is not a record, and (b) the J7 "outpace Nvidia Thor-X" claim is the first genuinely aspirational technical promise — until 2026, every product timeline was conservative relative to what got delivered. If the J7 narrative cools or slips, the credibility score should be re-rated.

6. What the Story Is Now

Horizon is now a full-stack autonomous driving platform company with three legs the market has not finished pricing:

1. The China ADAS franchise is real and durable — 47.7% domestic share in ADAS, 44% in NOA for domestic OEMs, 27 OEM customers and 290 car models. This leg is no longer disputed by analysts; it is the floor.

2. The HSD/AD upmarket move is the key uncertainty. 22,000 units in 2025 → 400,000 guided for 2026 is a step-change that depends on Chery, Volkswagen and BYD all shipping HSD-equipped models on schedule. Hit it and Horizon becomes the credible Nvidia-alternative for sub-RMB200K vehicles; miss it and the "platform" framing starts to unwind back to "chip vendor."

3. The robotics/embodied-AI optionality (Riemann BPU, HoloMotion/HoloBrain open-source models, "China's largest computing platform for consumer-grade robotics") is option value, not a base case. It is what Yu Kai talked about in December 2025 when 12,000 HSD activations is genuinely a small number and he needed a bigger story. Reasonable to discount entirely in valuation.

De-risked since IPO:

• Capital adequacy (¥15.4B+ cash, gearing 41.5% vs 255.4%)
• Top-line growth durability (5 consecutive years of >50% growth)
• Margin structure (gross margin 77.3% in FY2024, license & services at 92%)
• Volkswagen relationship (HSD platform integration deepened in April 2025)

Still stretched:

• Path to GAAP profitability is 2027 in sell-side models, and depends on operating leverage no large-scale chip company has yet demonstrated in this configuration
• CARIZON JV is consuming roughly ¥1B/year of incremental losses with no public turnaround date
• Valuation at ~20x P/S and ~32x LTM revenue for an unprofitable company prices in a near-perfect HSD ramp
• J7 vs Nvidia framing risks setting up the first management credibility test if the chip slips
• Stock has lost ~45% from January 2025 peak to May 2026 — the market is not fully convinced